ALENDRONATE TEVA 10 mg, tablet 28 tablets
Active ingredients: Alendronic acid, Alendronate monosodium monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALENDRONATE TEVA 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 28 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65028022CIP73665036CIP133400936650367Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALENDRONATE MONOSODIQUE MONOHYDRATÉcomprimé | 11,6 mg · un comprimé | SA |
| ACIDE ALENDRONIQUEcomprimé | 10 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.